chrisvoncsefalvay/vaers-outcomes huggingface dataset:
pt recvd vax;devel stinging & numbness in shoulder & arm;in er;elev BP & hyperventilation;dx not done yet;pt said cardiac problems have been ruled out; pt believes has nerve damage from flu vax;
Client was vaccinated with J&J vaccine on 3/31/2021.  Experienced Covid symptoms on 9/20 - nasal congestion, runny nose.  Tested + with PCR on 9/21.   Reported as a case of breakthrough Covid disease in a fully vaccinated person
By 7pm the day I received the vaccine, I started to feel bad. I went to the bathroom and was bleeding. I would fill the toilet bowl with blood the entire night until the next morning. It was discharging vagina my and through urine.  I had bad cramping each time I had to pee.  The next day the blood went away but the cramping continued and is still severe on Friday 9/3.  I have wondered if I have a UTI.  It feels like I?m going into labor.
Patient with prior COVID infection April 2020. He received 2nd Pfizer COVID vaccine 8/27/21. The morning of 8/28 developed nausea, fever, chills. 8/28 had brief chest pain that resolved. 8/29 developed chest pain for 3 hours. Presented to hospital with myocarditis- Troponins 737, 707 and ST elevations on EKG. Currently 4 days post vaccine, chest pain resolved though with persistent EKG changes.
dose given to 17 year old; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (dose given to 17 year old) in a 17-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007D21A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jul-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (dose given to 17 year old). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (dose given to 17 year old) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.   No treatment information was provided.
This is a spontaneous report from a contactable physician. A 44-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; lot number: EL1284), via an unspecified route of administration on 08Jan2021 08:00 at SINGLE DOSE at left arm for COVID-19 immunization. The patient's medical history was not reported. The patient is not pregnant. There were no concomitant medications. The patient received first dose of BNT162B2 on 18Dec2020 08:00 AM at left arm lot number= EJ1685. On 09Jan2021 11:00, the patient experienced right tinnitus. The patient did not receive treatment for the event. The outcome of the event was not recovered.
Pt. was given vaccine aprox. 12PM, had eaten breakfast that morning. Once Pt. was home about 4pm patient felt faint, lightheaded and nauseas. Injection site and arm were in pain for several days following. Mother found patient on floor the same day, patient was feeling faint, was given TUMS and rested. Patient felt faint about 24hrs. after injection.
States the next day late afternoon she noticed itching to both eyelids.  The right eyelid was worse than the left.  The itch feeling continued into the weekend.  Today (01/31/2023 Tuesday) is she is better and denies any itchy feeling but does state eyelids feel dry.
No adverse effect reported; the adult patient was inadvertently administered a pediatric dose of V AQT A; the adult patient was inadvertently administered a pediatric dose of V AQT A; This spontaneous report was received from a registered nurse and refers to an adult patient of unknown age and gender. There was no information regarding patient's pertinent medical history, drug reactions, allergies and concomitant therapies provided. On 02-NOV-2017, the patient was inadvertently administered a pediatric dose of hepatitis a vaccine, inactivated (VAQTA) injection, vial 25/0.5 (unspecified) (lot # N017094 has been verified to be a valid lot number, expiration date 31-AUG-2018) (exact dose, route of administration and anatomical location were not reported) for prophylaxis. No adverse effects were reported. The outcome of the events was not reported.
Elevated blood pressure 152/96 PRN clonidine 0.1 mg given x1 Lasix increased to 40 mg BID
felt sleepy/slept; Tired; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 65 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 12Mar2021 (Lot number: EN6206) at the age of 65 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: SOMNOLENCE (non-serious) with onset 13Mar2021, outcome "unknown", described as "felt sleepy/slept"; FATIGUE (non-serious) with onset 13Mar2021, outcome "recovered" (16Mar2021), described as "Tired".  Additional Information: Investigational assessment was done for dose 1. Patient stated that she was tired and slept. Tired adverse event started, the day after the first vaccine. Patient slept abnormally for 4 days and then she was okay. Sleeping and kept hoping it would go away like the first one but states it is going on 2 weeks now and it is so painful. Patient reported that she was on insurance and not everything recovered. Stated she wants to know if this is normal or if she should go to hospital.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021426776 same reporter/drug, different patient/AE
Mom gave Tylenol prior to vax and another dose at 4 PM. Pt went to bed at 8 PM. She awoke at between 9 and 10 PM acting strange, eyes crossing, seizing with a temperature of 105-106. She was taken to the ER. She had multiple seizures in ER. She was admitted for 2 days and treated with Phenobarbital. She was diagnosed as having febrile seizures. She was diagnosed with central auditory processing disorder, severe learning disability and language and speech disorder.
Red, swollen, itch started about 24 hrs after administered. Know, hurts to touch.
01/10/22 presents to ED for "potential seizure" "fever". PMHx of " ADD, Anxiety, Depression"
A year after last vaccine, tested positive for COVID-19. Took a home test and was prescribed PAXLOVID.
World closing in on me; freezing cold; sweating; fell off the toilet seat; peed on the floor.
Wheezing & cough x 1-2 hours; Fever 100 degrees & body aches today 11/6/13.
This spontaneous case was reported by a consumer and describes the occurrence of ORAL HERPES (Fever blister in her mouth), PERIPHERAL SWELLING (Left hand became Swollen and both feet became Swollen), RASH (She started Rash on both legs), MYALGIA (Left Arm was hurting) and NAUSEA (Nauseous) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 050C21A) for COVID-19 vaccination. No Medical History information was reported. On 17-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Jun-2021, the patient experienced MYALGIA (Left Arm was hurting) and NAUSEA (Nauseous). On 24-Jun-2021, the patient experienced ORAL HERPES (Fever blister in her mouth) and PERIPHERAL SWELLING (Left hand became Swollen and both feet became Swollen). On 28-Jun-2021, the patient experienced RASH (She started Rash on both legs). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Rash on leg, at an unspecified dose and frequency. At the time of the report, ORAL HERPES (Fever blister in her mouth), PERIPHERAL SWELLING (Left hand became Swollen and both feet became Swollen), MYALGIA (Left Arm was hurting) and NAUSEA (Nauseous) outcome was unknown and RASH (She started Rash on both legs) was resolving. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. On 8-Jul-2021, the rash faded a little but still visible. No relevant concomitant medications were reported.
Leg weakness/collapse leading to falls, ongoing. Hiccups, began at 24 hrs continued for 2 days .
States her stomach hurts, nauseated. Her mom states she gets nervous about things. She was very nervous this morning and woke up at 5am. Wasn't hungry for much breakfast. BP 92/64 Apical 80.
C/O H/A  AT FRONTAL/TEMPORAL AREAS,  BP 90/50 P86, SPO2 97,PAIN5/10,  PT STATES SHE HAD NOT EATEN WAS AT FUNERAL. DENIES SOB, DAUGHTER DRIVER. 3:50 STATES SHE IS READY TO GO HOME,A/O X3. PAIN 4/10.  BP 100/60,.
Within 5 mins of receiving the vaccine, patient collapsed, skin turned red, had difficulty breathing and "strange feeling in throat" on her way to the 15 minute observation room. 911 was called and  2 Pharmacists rushed to her and one administered an epinephrine pen. Patient could breathe more deeply after the epi pen administered.  One pharmacist stayed with her in case another dose of epinephrine needed to be administered, once the paramedics arrived the pharmacist left the room so they could care for the patient.
He was playing basketball at the time and he had some shortness of breath. He had been given albuterol for exercising. I took him to the clinic to get a refill and they identified an murmur. I took him to his PCP 12/13/2021 for a physical and they heard the murmur as well and scheduled a visit with cardiology. That visit was 12/15/2021 and they did EKG, ECG and they identified a benign murmur.
Urticaria, tachycardia at 10 minutes post injection in left arm and neck Treated with oral cetirizine and montelukast. Resolved within 15 minutes of treatment. Discharged in good condition with PO diphenhydramine as needed.
Information has been received from a medical assistant concerning a female who was vaccinated with a dose of GARDASIL. Subsequently, the patient experienced shortness of breath. She had a hard time getting out of bed for 2 days for unspecified reasons and was admitted to the ICU. The patient's shortness of breath persisted. No other details. Shortness of breath was considered to be immediately life-threatening by the medical assistant. Additional information has been requested.
14 APR ED. 18 APR PCM VISIT FOR ACUTE PERICARDITIS - CARDIOLOGY AND IMMUNIOLOGY CLINIC CONSULTS. 20 APR PRM: SX: SOB AND CP/DISCOMFORT - ACUTE PERICARDITIS. 23 APRIL: FOLLOW-UP WITH CARDIOLOGIST.
In right shoulder didn't start aching till 7:00 last night. Woke up at around 8:30 am shivering, but I wasn't cold. Had a fever of 101.9. Couldn't barely get up or even shower legs were numbed, shoulder barely move it.
no additional AE reported; Caller reports that an adult patient received an expired dose of VAQTA today; This spontaneous report was received from a pharmacist and refers to an Adult patient of unknown age and gender. There was no information about patient's concomitant medications, concurrent conditions or pertinent medical history.  On 13-OCT-2021, the patient was vaccinated with a dose of hepatitis a vaccine, inactivated(VAQTA), 1 milliliter, lot number S037821, expiration date reported as 17-JAN-2021 but upon internal validation established as 07-JAN-2021 (Expired product administered). No additional adverse event reported.
What looked like baby acne started around 7/15/2018. I took her to her 2 month well check on 8/15/18, at that time her baby acne was clearing but she still had a red bumpy rash on the sides of her face. I didn't ask the Dr about it at the time because I thought it might still be leftover baby acne. However, the sides of her face never cleared and the rash appeared on her arms and legs. It continued to worsen and showed up on her chest, stomach, back, and scalp by about mid-September. I took her to her 4 month well check on 10/16/2018 and shared my concerns with her worsening rash. My daughter was seen by a nurse practitioner that day who confirmed that she has Eczema. I've spoken to my husband, he has no known allergies and never had eczema and I have no known allergies or eczema.
04/03/2021 Itchiness on belly, arms, face, armpits Rashes Swellings like mosquito-bites wherever scratched, on right upper arms, and on hands at night when sleeping Tiredness which could be relieved by toileting Pain in hands from blood flow when clutching and moving 04/04/2021 Pain in upper arm, including left upper arm where dose 1 of Pfizer vaccine was given
I developed a pretty severe outbreak of genital herpes. I had not had an outbreak like this since I contracted it 22 years ago.; This is a spontaneous report from a contactable consumer (patient).   A 54-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: ER8730), via an unspecified route of administration, administered in Left arm on 29Mar2021 at the age of 54-years-old as 2nd dose, single for covid-19 immunisation. Medical history included asthma, hypothyroidism from an unspecified date, Allergies to medications, food, or other products augmentin & CIPRO, genital herpes from an unspecified date and had not had an outbreak like that since she contracted it 22 years ago. Concomitant medication included levothyroxine (LEVOTHYROXINE) taken for an unspecified indication, on an unspecified date received within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took first dose of historical vaccine, bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: En6199), via an unspecified route of administration, administered in Left arm on 08Mar2021 13:30 at the age of 54-years-old as single dose for covid-19 immunisation. The patient previously took augmentin [amoxicillin;clavulanic acid] and cipro [ciprofloxacin] and experienced drug allergy. The patient was diagnosed with COVID-19 prior to vaccination. The patient has not been tested for COVID-19 since the vaccination. On 08Apr2021, the patient developed a pretty severe outbreak of genital herpes. She had not had an outbreak like that since she contracted it 22 years ago and no treatment was received for the adverse event. The patient underwent lab tests and procedures which included COVID-19 (sars-cov-2 test): positive on an unspecified date. The reporter assessed events as non-serious with no seriousness criteria of resulting in death, Caused/prolonged hospitalization, Disabling/Incapacitating, Congenital anomaly/birth defect. The outcome of event was recovering.  No follow-up attempts are needed. No further information is expected.
Rash on arm, using hydrocortisone and benadryl, waiting for it to resolve
After vaccine pt went to observation area .He felt hot and asked staff for H2O. When staff returned c H2O he stated he felt light headed. Staff concerned he was going to pass out so they assisted him from chair to ground with legs e levated . Emergency number and onsite MDcalled . Pt was unresponsive c aBormal breathing and seizure like activity . Epi 0.3mg administered in right thigh. Pt became responsive and breathing 15 RR a minute. Pt diaphoretic c rash on upper extremities. VSS. EMS arrived and transported pt to local ED for evaluation.
Blurry vision, light headed, sweating, nausea. Had patient remove mask and take some deep breaths. Offered some water to drink to re-hydrate. Patient felt much better right away. Pharmacist sat with patient for an additional 15 minutes to monitor for worsening or additional symptoms. Patient showed only signs of improvement. Helped patient stand. No lightheadedness or dizziness upon standing. Patient left pharmacy.
Information has been received on 15-JUL-2016 from a registered nurse. The registered nurse reported that on unknown dates, multiple patients (ages and gender unknown) were vaccinated with improperly stored GARDASIL 9 lot # M003659 expiration date 20-SEP-2017, LIQUID PEDVAXHIB lot # L051124 expiration date 14-OCT-2018 and M-M-R II lot # L036851 expiration date 23-SEP-2017. The temperature excursion information included the highest temperature of 53.2 degrees Fahrenheit for 30 minutes. No adverse effects were reported. Additional information has been requested.
Initial report received on 06 May 2008 from a Nurse Practitioner in the United States. A 13 year-old-patient, with past medical history of mild depression, had received on 11 March 2008 an intramuscular right deltoid injection of MENACTRA (lot # U2546AA); a left deltoid dose of GARDASIL (Lot # 1487U); and a right deltoid dose of VAQTA vaccine (Lot # AHAVE215AA) The route and site of administration was not provided for the VAQTA and GARDASIL vaccines. Two days post-vaccination, the patient complained of lightheadedness, dizziness, headache, fatigue, tightness in her chest, and on episode of heart palpitations lasting about two minutes. The patient required evaluation by a physician, but no relevant diagnostic tests or laboratory data were performed. Treatments received were not reported. At the time of this report, the patient had recovered.
Sciatic nerve pain; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3184) via an unspecified route of administration in the arm right on 19Sep2021 at 11:30 (at the age of 47-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history and known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications included ibuprofen (MANUFACTURER UNKNOWN) and paracetamol (ACETAMINOPHEN); all for an unknown indication from an unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3184) via an unspecified route of administration in the arm right on 22Aug2021 at 10:45 (at the age of 47-year-old) as a single dose for COVID-19 immunisation. On 19Sep2021 at 23:00, the patient experienced sciatic nerve pain. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event sciatic nerve pain was not resolved at the time of this report.
No additional AEs were reported; The nurse reported that 33 patients received improperly stored vaccines.; This spontaneous report was received from a Licensed Practical Nurse and refers to a patient of unknown age and gender. Information regarding the patient's concomitant therapies, concurrent conditions, medical history and historical drugs was not provided.  On 11-MAR-2022, the patient was vaccinated with improperly stored Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (LIQUID PEDVAXHIB) (dosage regimen was not reported), lot # U026217 and expiration date 02-NOV-2023 administered as prophylaxis.   The improperly stored dose of the suspect vaccine experienced a temperature excursion of 34.3 degree fahrenheit (F) for 55 minutes; no previous temperature excursions were reported.  The call was made due to a digital data logger. No adverse symptoms were reported.; Sender's Comments:  US-009507513-2204USA001821: US-009507513-2204USA001816: US-009507513-2204USA001791:
Approx 5 min after getting GARDASIL pt passed out for 1-3 min. Pt was moved to a laying post. and monitored for 30 min.
being dizzy; he "can't stand straight, I almost fell backwards; This is a spontaneous report from a contactable consumer (patient).   A 99-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot Number: Unknown), dose 2 via an unspecified route of administration on 15Apr2021 as SINGLE DOSE for covid-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date around three days after the vaccination the patient felt dizzy, and he could not stand straight he almost fell backwards. It was reported that dizziness become worse. Patient asked about how long would side effects last and wanted to know treatment recommendations. Outcome of events was not resolved.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Allergies acting up right now; This is a spontaneous report from a contactable consumer (patient's husband). A 44-years-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number: Not reported) via an unspecified route of administration on Mar2021 and first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number: Not reported) via an unspecified route of administration on Feb2021 both as a single for COVID-19 immunization. The medical history was not reported. Concomitant medications included antihistamine for allergies, over the counter. Reporter stated that the patient started having symptoms about three weeks ago. The patient got her shots in February and March and her allergies acting up right now. Patient stated that she was fine, it's just her allergies, it's allergy season right now: ragweed, pollen, and mold was high. The outcome of the event was unknown.  Information about lot/Batch number is requested.
p/vax pt began running fever 101-102 & broke out c/ red spots all over; mom took to ER pt had T100; 8/23 recovered
Swelling,  redness and soreness and a knot in vaccine site for a month. As of today I still have a knot under the injection site and soreness. Cannot sleep on that arm and some pain with active or not. Achy joints and fatigue.
Adverse effect of other vaccines and biological substances, initial encounter on 2020-07-25.
Information has been received from a 45 year old male registered nurse who on 8/24/05 (also reported as 8/23/05) was vaccinated with a 0.5 ml IM dose in the left arm of PNEUMOVAX 23 (lot # 649914/0578P). It was reported that a dinner time on the same day, on 8/24/05, the patient experienced chills, body aches, watery eyes, joint pain and fever which progressively got worse in the evening. By early morning on 4/25/05 the fever was 103.5. The patient could not raise his left arm parallel to his shoulder. At that time the injection site remained clear with no swelling. The patient called the physician for phone follow up and asked if the event may have been the flu. Treatment with acetaminophen and ibuprofen was noted as needed for fever. The patient reported that the fever subsided last night, on 8/25/05, and was unable to raise his arm higher today, but the soreness and body aches still remained. It was also reported that the left arm injection site was swollen to the size of a baseball and felt warm to the touch. The patient stated that he missed a day of work because of the event. It was reported that the patient was recovering. There were no laboratory or diagnostic tests performed. No product quality complaint was involved. No other information was provided. The events were considered to be disabling and other important medical events by the reporter. Additional information has been requested.
Back of neck became very sore and stiff. Near the base of patient's skull. Began sneezing frequently and became very congested. Throat became increasingly sore bilaterally. Nose and eyes dried out as well during this time.
The patient is experiencing pain and neuropathy from the elbow down in her left arm. There is no rash. There is a palpable knot on the patient's forearm.
pt recv vax 25MAR99 seen 29MAR99 for fever 103.9R;seen 31MAR for dark pink rash on abd, back, chest, neck & face;fever gone;child playing & eating;